Discordance between CD4 cell count and percentage associated with markers of liver disease in HIV/hepatitis C co-infected people
Liver fibrosis increases risk of discordance in CD4 cell count and percentage in HIV-positive people
Point-of-care CD4 test improves retention and treatment initiation in Mozambique
Variations in mitochondrial DNA affect CD4 gains in black patients taking successful HIV therapy
Poor CD4 cell recovery after starting HIV treatment should be a cause for concern, close monitoring needed
How best to deploy point-of-care CD4 cell testing in resource-limited settings?
